Evidence map›Paper›PMID 25414100›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2015

Loss of hepatocyte EGFR has no effect alone but exacerbates carbon tetrachloride-induced liver injury and impairs regeneration in hepatocyte Met-deficient mice.

Lawrence A Scheving, Xiuqi Zhang, Mary C Stevenson, David W Threadgill, William E Russell

Abstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Liver regeneration: biological and pathological mechanisms and implications.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  9. Article
  10. Review
  11. Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2018
    Article
  12. Epidermal Growth Factor Receptor Signaling Disruption by Endocrine and Metabolic Disrupting Chemicals.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Article
  13. Polychlorinated biphenyls disrupt hepatic epidermal growth factor receptor signaling.Xenobiotica; the fate of foreign compounds in biological systems · 2017
    Article
  14. Article
  15. Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Article
  16. Article
  17. EGFR Signaling in Liver Diseases.International journal of molecular sciences · 2015
    Review
  18. Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis.American journal of physiology. Gastrointestinal and liver physiology · 2015
    Article
  19. Transgenic expression of the human growth hormone minigene promotes pancreatic β-cell proliferation.American journal of physiology. Regulatory, integrative and comparative physiology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lawrence A SchevingDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee; Digestive Disease Research Center, Vanderbilt University Medical Center, Nashville, Tennessee; lawrence.a.scheving@vanderbilt.edu.
Xiuqi ZhangDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee;
Mary C StevensonDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee;
David W ThreadgillDepartment of Veterinary Pathobiology, Texas A&M University, College Station, Texas; and Department of Molecular and Cellular Medicine, Texas A&M University, College Station, Texas.
William E RussellDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee; Digestive Disease Research Center, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt Diabetes Center, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee;

Funding

ERBB SIGNALING IN LIVER ONTOGENY AND REGENERATIONR01DK053804 · NIDDK · VANDERBILT UNIVERSITY · PI RUSSELL, WILLIAM E · 1998 to 2013
$3.7M
ERBB receptors in normal and cancerous colon biologyR01CA092479 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THREADGILL, DAVID W. · 2001 to 2012
$2.8M
ErbB Receptor Signaling in DEN-induced Murine HepatocarcinogenesisR21CA149708 · NCI · VANDERBILT UNIVERSITY · PI RUSSELL, WILLIAM E · 2010 to 2011
$362k
NCI NIH HHS R01CA092479NCI NIH HHS R21CA149708NIDDK NIH HHS R01DK53804
6 · The paper itself

Abstract

The role(s) of the epidermal growth factor receptor (EGFR) in hepatocytes is unknown. We generated a murine hepatocyte specific-EGFR knockout (KO) model to evaluate how loss of hepatocellular EGFR expression affects processes such as EGF clearance, circulating EGF concentrations, and liver regeneration following 70% resection or CCl4-induced centrilobular injury. We were able to disrupt EGFR expression effectively in hepatocytes and showed that the ability of EGF and heregulin (HRG) to phosphorylate EGFR and ERBB3, respectively, required EGFR. Loss of hepatocellular EGFR impaired clearance of exogenous EGF from the portal circulation but paradoxically resulted in reduced circulating levels of endogenous EGF. This was associated with decreased submandibular salivary gland production of EGF. EGFR disruption did not result in increased expression of other ERBB proteins or Met, except in neonatal mice. Liver regeneration following 70% hepatectomy revealed a mild phenotype, with no change in cyclin D1 expression and slight differences in cyclin A expression compared with controls. Peak 5-bromo-2'-deoxyuridine labeling was shifted from 36 to 48 h. Centrilobular damage and regenerative response induced by carbon tetrachloride (CCl4) were identical in the KO and wild-type mice. In contrast, loss of Met increased CCl4-induced necrosis and delayed regeneration. Although loss of hepatocellular EGFR alone did not have an effect in this model, EGFR-Met double KOs displayed enhanced necrosis and delayed liver regeneration compared with Met KOs alone. This suggests that EGFR and Met may partially compensate for the loss of the other, although other compensatory mechanisms can be envisioned.

Indexed as

Liver RegenerationAnimalsCarbon TetrachlorideChemical and Drug Induced Liver InjuryCyclin ACyclin D1Epidermal Growth FactorErbB ReceptorsHepatocytesMiceNeuregulin-1Proto-Oncogene Proteins c-metReceptor, ErbB-3Carbon TetrachlorideCyclin ACyclin D1Epidermal Growth FactorErbB ReceptorsNeuregulin-1Proto-Oncogene Proteins c-metReceptor, ErbB-3carbon tetrachlorideEGFRhepatectomyliverMetsubmandibular gland

Identifiers

PMID25414100
PMCPMC4346751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.